NewEdge Advisors’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$102K Sell
8,550
-1,950
-19% -$28K ﹤0.01% 2748
2025
Q4
$162K Hold
10,500
﹤0.01% 2641
2025
Q3
$227K Hold
10,500
﹤0.01% 2352
2025
Q2
$233K Buy
+10,500
New +$233K ﹤0.01% 2142
2023
Q3
Sell
-11,012
Closed -$495K 3634
2023
Q2
$495K Buy
+11,012
New +$420K 0.01% 1193
2023
Q1
Sell
-41
Closed -$1.14K 4036
2022
Q4
$1.14K Buy
+41
New +$1.09K ﹤0.01% 2998

Other funds holding SGRY

NewEdge Advisors's SGRY Position: Q1 2026 in Review

NewEdge Advisors reduced its Surgery Partners (SGRY) stake by 19% in Q1 2026, selling an estimated $28K and leaving 8,550 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #2748.

NewEdge Advisors first reported a position in SGRY in Q4 2022 and has held it in 6 quarters since. The position peaked at $495K in Q2 2023. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • NewEdge Advisors held 8,550 shares of Surgery Partners worth $102K as of Q1 2026.
  • NewEdge Advisors sold 1,950 Surgery Partners shares in Q1 2026, an estimated $28K.
  • Surgery Partners made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2748 holding.
  • NewEdge Advisors first reported a position in Surgery Partners in Q4 2022 and has held it in 6 quarters since.
  • NewEdge Advisors's Surgery Partners position peaked at $495K in Q2 2023.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.